|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-396 and Co-administration of CKD-501 and D759 in Healthy Adults
The purpose of this study is to evaluate the pharmacokinetics and safety of CKD-396.
100 项与 DPP-4 x PPARγ x PPARα 相关的临床结果
100 项与 DPP-4 x PPARγ x PPARα 相关的转化医学
0 项与 DPP-4 x PPARγ x PPARα 相关的专利(医药)